RxDoctor Payments Data

Laura Wiese, CNM

Advanced Practice Midwife · Porterville, CANPI 1720485329

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 41.9% of the total. Reporting peaked in 2021 at $610 and has fallen 94.1% since, to $36 in 2024. Among advanced practice midwife clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$891in general payments, 2019–2025

Across 32 payments — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$373
  • AbbVie$184
  • Therapeuticsmd, Inc.$77
  • Pfizer$62
  • Myovant Sciences Inc.$38
  • Organon$26
  • plus $131 from 7 others

What the payments were for

  • Food & beverage$891100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$891 in reported general payments places this provider in the 90th percentile of 451 advanced practice midwife providers in California.

See all advanced practice midwife providers in California

Medicare billing

Part B allowed, 2024
$4,703
Medicare patients
26
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol36$1,656
ProgesteroneProgesterone, Micronized18$624
Oxybutynin Chloride13$167

Paid to pharmacies, not to this prescriber.

Other advanced practice midwife in Porterville

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →